The Interplay Between Pediatric Atopic Dermatitis and Neurodevelopmental Disorders: Emerging Evidence, Mechanistic Insights, and Clinical Implications
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Xiaoya Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Neurodevelopmental Disorders. Die Arbeit nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Pudong New Area Health Commission, Clinical Research Plan of SHDC.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a common chronic inflammatory skin disease in children and is increasingly recognized as a systemic disorder with potential consequences beyond the skin. Growing evidence links pediatric AD to neurodevelopmental disorders, particularly attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), but the mechanisms and clinical implications remain incompletely understood. Systemic and neuroimmune inflammation, altered T-helper-cell and cytokine signaling, and genetic and epigenetic susceptibility may contribute to this association. Sleep disruption and psychosocial stress represent additional potential pathways linking skin inflammation with neurodevelopment. Stronger associations have been reported in children with severe or early-onset AD, multiple atopic comorbidities, and persistent sleep disturbance, highlighting the importance of disease heterogeneity. This narrative review integrates epidemiologic evidence and proposed mechanisms to examine the skin–brain axis in pediatric AD, with particular attention to high-risk phenotypes and implications for developmental surveillance and multidisciplinary management. Although current evidence supports an association, causality remains uncertain. Prospective studies integrating AD phenotypes, biomarkers, and neurodevelopmental assessments are needed to clarify these relationships and determine whether early effective AD treatment can modify long-term neurodevelopmental trajectories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
- Department of Dermatology, Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton TA1 5DA, UK.
- Allergy and Immunology Diagnostic and Treatment Center, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
ORCID-Profile: Xiaoya Ma
Förderung
- National Natural Science Foundation of China
- Shanghai Pudong New Area Health Commission
- Clinical Research Plan of SHDC
Zitieren
APA
Ma, X., Chen, Z., Anstey, A., Wan, P., & Deng, D. (2026). The Interplay Between Pediatric Atopic Dermatitis and Neurodevelopmental Disorders: Emerging Evidence, Mechanistic Insights, and Clinical Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209270
Vancouver
Ma X, Chen Z, Anstey A, Wan P, Deng D. The Interplay Between Pediatric Atopic Dermatitis and Neurodevelopmental Disorders: Emerging Evidence, Mechanistic Insights, and Clinical Implications. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209270
BibTeX
@article{Ma2026,
author = {Ma, Xiaoya and Chen, Zhuo and Anstey, Alexander and Wan, Pengjie and Deng, Dan},
title = {The Interplay Between Pediatric Atopic Dermatitis and Neurodevelopmental Disorders: Emerging Evidence, Mechanistic Insights, and Clinical Implications},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209270}
}
EUVIMED